HT
WST icon

Headlands Technologies’s West Pharmaceutical WST Stock Holding History

Headlands Technologies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,789
Closed -$1.92M – 1307
2025
Q2 		$1.92M Buy
8,789
+6,728
+326% +$1.44M 0.23% 89
2025
Q1 		$461K Buy
+2,061
New +$568K 0.05% 302
2023
Q3 		– Sell
-499
Closed -$191K – 1250
2023
Q2 		$191K Buy
+499
New +$178K 0.06% 288

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Headlands Technologies's WST Position: Q3 2025 in Review

Headlands Technologies sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 8,789 shares — an estimated $1.92M sold.

Headlands Technologies first reported a position in WST in Q2 2023 and held it in 3 quarters. The position peaked at $1.92M in Q2 2025. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Headlands Technologies reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 8,789 West Pharmaceutical shares in Q3 2025, an estimated $1.92M.
  • Headlands Technologies first reported a position in West Pharmaceutical in Q2 2023 and held it in 3 quarters.
  • Headlands Technologies's West Pharmaceutical position peaked at $1.92M in Q2 2025.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.